SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors

doi:10.1158/2159-8290.CD-22-1350

SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors

2023-10-31

20

PRE

AI

Pierre‐Emmanuel Bonté

Sebastián Amigorena *

DOI：10.1158/2159-8290.CD-22-1350

Original

Original request for help

Save

Abstract

En 中文

Failure of adoptive T-cell therapies in patients with cancer is linked to limited T-cell expansion and persistence, even in memory-prone 41BB-(BBz)-based chimeric antigen receptor (CAR) T cells. We show here that BBz-CAR T-cell stem/memory differentiation and persistence can be enhanced through epigenetic manipulation of the histone 3 lysine 9 trimethylation (H3K9me3) pathway. Inactivation of the H3K9 trimethyltransferase SUV39H1 enhances BBz-CAR T cell long-term persistence, protecting mice against tumor relapses and rechallenges in lung and disseminated solid tumor models up to several months after CAR T-cell infusion. Single-cell transcriptomic (single-cell RNA sequencing) and chromatin opening (single-cell assay for transposase accessible chromatin) analyses of tumor-infiltrating CAR T cells show early reprogramming into self-renewing, stemlike populations with decreased expression of dysfunction genes in all T-cell subpopulations. Therefore, epigenetic manipulation of H3K9 methylation by SUV39H1 optimizes the long-term functional persistence of BBz-CAR T cells, limiting relapses, and providing protection against tumor rechallenges.

Keywords:

CELLS

PERSISTENCE

HETEROCHROMATIN

STEMNESS

SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors

Abstract

Journal

Organization